Cargando…

Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia

Diabetes mellitus (DM) is characterized by the appearance of progressive kidney damage, which may progress to end-stage kidney disease. The control of hyperglycemia is usually not sufficient to halt this progression. The kidney damage is quantitatively and qualitatively different in the two forms of...

Descripción completa

Detalles Bibliográficos
Autor principal: Viggiano, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650633/
https://www.ncbi.nlm.nih.gov/pubmed/37959313
http://dx.doi.org/10.3390/jcm12216848
_version_ 1785135825447550976
author Viggiano, Davide
author_facet Viggiano, Davide
author_sort Viggiano, Davide
collection PubMed
description Diabetes mellitus (DM) is characterized by the appearance of progressive kidney damage, which may progress to end-stage kidney disease. The control of hyperglycemia is usually not sufficient to halt this progression. The kidney damage is quantitatively and qualitatively different in the two forms of diabetes; the typical nodular fibrosis (Kimmelstiel Wilson nodules) appears mostly in type 1 DM, whereas glomerulomegaly is primarily present in type 2 obese DM. An analysis of the different metabolites and hormones in type 1 and type 2 DM and their differential pharmacological treatments might be helpful to advance the hypotheses on the different histopathological patterns of the kidneys and their responses to sodium/glucose transporter type 2 inhibitors (SGLT2i).
format Online
Article
Text
id pubmed-10650633
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106506332023-10-30 Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia Viggiano, Davide J Clin Med Review Diabetes mellitus (DM) is characterized by the appearance of progressive kidney damage, which may progress to end-stage kidney disease. The control of hyperglycemia is usually not sufficient to halt this progression. The kidney damage is quantitatively and qualitatively different in the two forms of diabetes; the typical nodular fibrosis (Kimmelstiel Wilson nodules) appears mostly in type 1 DM, whereas glomerulomegaly is primarily present in type 2 obese DM. An analysis of the different metabolites and hormones in type 1 and type 2 DM and their differential pharmacological treatments might be helpful to advance the hypotheses on the different histopathological patterns of the kidneys and their responses to sodium/glucose transporter type 2 inhibitors (SGLT2i). MDPI 2023-10-30 /pmc/articles/PMC10650633/ /pubmed/37959313 http://dx.doi.org/10.3390/jcm12216848 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Viggiano, Davide
Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia
title Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia
title_full Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia
title_fullStr Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia
title_full_unstemmed Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia
title_short Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia
title_sort mechanisms of diabetic nephropathy not mediated by hyperglycemia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650633/
https://www.ncbi.nlm.nih.gov/pubmed/37959313
http://dx.doi.org/10.3390/jcm12216848
work_keys_str_mv AT viggianodavide mechanismsofdiabeticnephropathynotmediatedbyhyperglycemia